Skip to main content
TipRanks
Go Ultimate75% OFF

Thomas Mckearn Insider Profile

4 Followers

Thomas Mckearn, President, R&D at Traws Pharma, holds 100.22K shares in Advaxis (Ticker: ADXS), holds 3.33K shares in Traws Pharma (Ticker: TRAW). Most recently, Thomas Mckearn Sold ― shares of Advaxis on Dec 21, 2016 for an estimated value of $99.51K.

Thomas Mckearn's Trading History

ADXS
Advaxis
Dec 21, 2016―Informative Sell99.51K$60.43K
TRAW
Traws Pharma
Jul 30, 2013President, R&DInformative Buy49.99K$836.58

You May Also Like

Thomas Mckearn insider profile FAQ

What is the percentage of profitable transactions made by Thomas Mckearn?
The percentage of profitable transactions made by Thomas Mckearn is 33%.
What is the average return per transaction made by Thomas Mckearn?
The average return per transaction made by Thomas Mckearn is 14.60%.
What stocks does Thomas Mckearn hold?
Thomas Mckearn holds: TRAW, ADXS stocks.
What was Thomas Mckearn’s latest transaction?
Thomas Mckearn’s latest transaction was an Informative Sell of $99.51K.
What was Thomas Mckearn's most profitable transaction?
Thomas Mckearn’s most profitable transaction was an Informative Sell of ADXS stock on December 21, 2016. The return on the trade was 62.30%.
What is Thomas Mckearn's role in Traws Pharma?
Thomas Mckearn's role in Traws Pharma is President, R&D.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.